BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...

January 25, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

January 20, 2022 | News

Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

January 19, 2022 | News

Gaumard Scientific to Unveil the World's Most Advanced Multidisciplinary Patient Simulator, HAL® S530

Gaumard Scientific Co., an industry leader of simulation technology for healthcare education and training, today announced that HAL® S5301, the w...

January 17, 2022 | News

Seegene Unveils Blueprint for the Future of Molecular Diagnostics

Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...

January 13, 2022 | News

Illumina collaborates with Nashville Biosciences to accelerate medicines development

Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

January 11, 2022 | News

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will i...

January 07, 2022 | News

Illumina Enters Co-Development Partnership with SomaLogic

Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Prot...

January 06, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

January 03, 2022 | News

Stay Connected